Influenza immunization is the most effective strategy to reduce a person’s risk of developing influenza and its related complications. NACI has updated their recommendations for the 2020-2021 influenza season. There are also several vaccine options that can be considered to protect your patients from an infection that affects 5% to 10% of adults and 20% to 30% worldwide annually. This program reviews current NACI recommendations, new evidence on the different vaccine options and strategies to protect your patients from influenza.
Influenza 2020-2021 Update for Pharmacists – A New Vaccine Option for Patients
CAN-eng
$0
gratuit
CCCEP
1 hour
Maladie infectieuse
1.5 Credits
Description du cours
Détails du cours
Date d'expiration : 2021-11-23
Métiers: Pharmacie
Faculté
Mark Loeb, MD, FRCPC, MSc
Melissa Sayed, PharmD, B.Sc
Ajit Johal, BSc (Pharm), RPh, BCPP, CDE, CTH
Accréditation
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 1.5 CEUs.
CCCEP File Number: 1066-2020-3110-I-P
Objectif(s) d'apprentissage
After completion of the program, participants will be able to:
- Describe the key recommendations from the 2020-2021 NACI statement on influenza immunization
- Determine the potential role of cell-based influenza vaccines
- Describe important factors to consider with influenza immunization in older adults
- Educate patients on the different vaccine options for older adults
- Recognize the potential impact of COVID-19 on influenza immunization
- Describe the increasingly important role in influenza immunization